SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR), supporting efforts to ensure environmental safety and sustainability. The flexible system covers a variety of configurations, […]
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education NEW YORK — BioAro successfully launched its presence in the UK at the Royal Society on August 29th, 2024. BioAro’s UK launch marks a significant step in the company’s mission to revolutionize precision medicine. Leveraging advanced AI-driven genomic analysis, […]
Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. The new-gen SOPHiA DDM™ Platform offers a new architecture designed to more efficiently compute large amounts of data at-scale, while elevating customer experience with […]
Illumina announces global expansion plans in India. At the Illumina India Genomics Summit on Friday 30 August 2024, Illumina announced the establishment of a Global Capability Center in Bengaluru, India, as an investment to expand its technology workforce in support of a global customer base. India is on its way to becoming the world’s third […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, welcomes the European Court of Justice’s (ECJ’s) judgment today ruling that the European Commission did not have jurisdiction over Illumina’s acquisition of GRAIL. Today’s judgment confirms Illumina’s longstanding view that the European Commission exceeded its authority by asserting jurisdiction over this […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers an affordable entry point into routine, high-performance single cell […]
Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the […]
BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets […]
Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO — Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have […]
Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
